Scott Moseley

1.4k total citations
22 papers, 856 citations indexed

About

Scott Moseley is a scholar working on Endocrinology, Diabetes and Metabolism, Rheumatology and Orthopedics and Sports Medicine. According to data from OpenAlex, Scott Moseley has authored 22 papers receiving a total of 856 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Rheumatology and 9 papers in Orthopedics and Sports Medicine. Recurrent topics in Scott Moseley's work include Alkaline Phosphatase Research Studies (18 papers), Heterotopic Ossification and Related Conditions (8 papers) and Bone health and treatments (7 papers). Scott Moseley is often cited by papers focused on Alkaline Phosphatase Research Studies (18 papers), Heterotopic Ossification and Related Conditions (8 papers) and Bone health and treatments (7 papers). Scott Moseley collaborates with scholars based in United States, Canada and United Kingdom. Scott Moseley's co-authors include Michael P. Whyte, Cheryl R. Greenberg, David D. Thompson, Priya S. Kishnani, Kenji P. Fujita, Nicholas Bishop, Christine Hofmann, Tatjana Odrljin, William H. McAlister and Dawn Phillips and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Hepatology and Journal of Bone and Mineral Research.

In The Last Decade

Scott Moseley

22 papers receiving 840 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott Moseley United States	12	733	474	272	202	191	22	856
Soyi Liu-Léage France	10	39 0.1×	96 0.2×	205 0.8×	77 0.4×	36 0.2×	21	404
Wolfgang Withold Germany	12	53 0.1×	44 0.1×	87 0.3×	102 0.5×	41 0.2×	23	394
Rodolfo Argueta United States	7	177 0.2×	21 0.0×	222 0.8×	109 0.5×	24 0.1×	9	537
Chiara Sonato Italy	9	40 0.1×	16 0.0×	72 0.3×	69 0.3×	76 0.4×	18	356
Stylianos Karvounaris Greece	7	34 0.0×	319 0.7×	17 0.1×	97 0.5×	22 0.1×	10	488
Elisa Y. Rhew United States	9	45 0.1×	244 0.5×	11 0.0×	44 0.2×	105 0.5×	13	404
Dihua Zhang China	8	24 0.0×	40 0.1×	57 0.2×	100 0.5×	18 0.1×	16	348
Sogol Amjadi United States	7	54 0.1×	248 0.5×	5 0.0×	39 0.2×	100 0.5×	10	457
Samir N. Tuma United States	8	25 0.0×	39 0.1×	23 0.1×	63 0.3×	43 0.2×	15	334
Kenneth E. Levin United States	12	155 0.2×	91 0.2×	3 0.0×	34 0.2×	66 0.3×	14	672

Countries citing papers authored by Scott Moseley

Since Specialization

Citations

This map shows the geographic impact of Scott Moseley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Moseley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Moseley more than expected).

Fields of papers citing papers by Scott Moseley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Moseley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Moseley. The network helps show where Scott Moseley may publish in the future.

Co-authorship network of co-authors of Scott Moseley

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Moseley. A scholar is included among the top collaborators of Scott Moseley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Moseley. Scott Moseley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liang, Tao, Linwen Zhang, Scott Moseley, et al.. (2022). Development and validation of a novel ICP-MS method to quantify different copper species in human plasma from patients with Wilson disease. Journal of Hepatology. 77. S526–S526. 2 indexed citations

Seefried, Lothar, Priya S. Kishnani, Scott Moseley, et al.. (2020). Pharmacodynamics of asfotase alfa in adults with pediatric-onset hypophosphatasia. Bone. 142. 115664–115664. 30 indexed citations

Hofmann, Christine, Paul Harmatz, Jerry Vockley, et al.. (2019). Efficacy and Safety of Asfotase Alfa in Infants and Young Children With Hypophosphatasia: A Phase 2 Open-Label Study. The Journal of Clinical Endocrinology & Metabolism. 104(7). 2735–2747. 57 indexed citations

Rush, Eric T., Scott Moseley, & Anna Petryk. (2019). Burden of disease in pediatric patients with hypophosphatasia: results from the HPP Impact Patient Survey and the HPP Outcomes Study Telephone interview. Orphanet Journal of Rare Diseases. 14(1). 201–201. 11 indexed citations

Whyte, Michael P., Edward Leung, William R. Wilcox, et al.. (2019). Natural History of Perinatal and Infantile Hypophosphatasia: A Retrospective Study. The Journal of Pediatrics. 209. 116–124.e4. 41 indexed citations

Whyte, MP, Scott Moseley, Nicolette C. Bishop, et al.. (2019). Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial. Yearbook of pediatric endocrinology. 1 indexed citations

Whyte, Michael P., Jill H. Simmons, Scott Moseley, et al.. (2018). Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial. The Lancet Diabetes & Endocrinology. 7(2). 93–105. 95 indexed citations

Kishnani, Priya S., Cheryl R. Greenberg, Frank Rauch, et al.. (2018). Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia. Bone. 121. 149–162. 110 indexed citations

Phillips, Dawn, et al.. (2018). Reliability and Validity of the 6‐Minute Walk Test in Hypophosphatasia. JBMR Plus. 3(6). e10131–e10131. 17 indexed citations

10.

Whyte, Michael P., Kenji P. Fujita, Scott Moseley, David D. Thompson, & William H. McAlister. (2018). Validation of a Novel Scoring System for Changes in Skeletal Manifestations of Hypophosphatasia in Newborns, Infants, and Children: The Radiographic Global Impression of Change Scale. Journal of Bone and Mineral Research. 33(5). 868–874. 35 indexed citations

11.

Kishnani, Priya S., Cheryl R. Greenberg, Andrew Denker, Scott Moseley, & Michael P. Whyte. (2017). Biochemical and physical function outcomes after 5 years of treatment with asfotase alfa in adolescents and adults with hypophosphatasia: phase 2 study results. Bone Abstracts. 5 indexed citations

12.

Whyte, Michael P., Katherine L. Madson, Dawn Phillips, et al.. (2016). Asfotase alfa therapy for children with hypophosphatasia. JCI Insight. 1(9). e85971–e85971. 126 indexed citations

13.

Weber, Thomas J., Eileen K. Sawyer, Scott Moseley, Tatjana Odrljin, & Priya S. Kishnani. (2016). Burden of disease in adult patients with hypophosphatasia: Results from two patient-reported surveys. Metabolism. 65(10). 1522–1530. 80 indexed citations

14.

Madson, Katherine L., Cheryl R. Greenberg, Scott Moseley, Tatjana Odrljin, & Michael P. Whyte. (2015). Asfotase Alfa: Sustained Efficacy and Tolerability in Children with Hypophosphatasia Treated for 5 Years. 84. 4 indexed citations

15.

Whyte, Michael P., Cheryl R. Greenberg, Keiichi Ozono, et al.. (2015). Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia. The Journal of Clinical Endocrinology & Metabolism. 101(1). 334–342. 186 indexed citations

16.

Weber, Thomas, Eileen K. Sawyer, Scott Moseley, Tatjana Odrljin, & Priya S. Kishnani. (2015). Burden of disease in children with hypophosphatasia: results from patient-reported surveys. Bone Abstracts. 2 indexed citations

17.

Hofmann, Christine, Cheryl R. Greenberg, Paul Harmatz, et al.. (2015). Improvement in bone manifestations and respiratory status in infants and young children with HPP treated with asfotase alfa: an update on the ENB-010-10 trial. Bone Abstracts. 2 indexed citations

18.

Bishop, Nicholas, Jill H. Simmons, Richard E. Lutz, et al.. (2014). Hypophosphatasia: Gross Motor Function and Height Improvement in Infants and Young Children Treated with Asfotase Alfa for up to 3 Years. 82. 2 indexed citations

19.

Madson, Katherine L., Cheryl R. Greenberg, Agustin Melian, et al.. (2014). Asfotase Alfa: Sustained Improved Growth and Function with Extended Treatment in Children with Hypophosphatasia. 82. 1 indexed citations

20.

McHutchison, John G., Mitchell L. Shiffman, Ramsey Cheung, et al.. (2005). A Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Trial of Merimepodib (VX-497) and Interferon-α in Previously Untreated Patients with Chronic Hepatitis C. Antiviral Therapy. 10(5). 635–643. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact